PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 20260 citationsOpen Access

Construction, expression, and evaluation of the naturally acquired humoral immune response against RMC-1 of Plasmodium vivax, a multistage chimeric protein

View Full Paper
AMAda MatosISIsabela SoaresLCLana Chaves

Key Points

  • This research aims to construct and evaluate the immune response against the RMC-1 chimeric protein of Plasmodium vivax.
  • Construction of the chimeric protein RMC-1
  • Expression of the protein in a suitable system
  • Evaluation of the humoral immune response elicited by the protein.
  • Characterization of the immune response indicates a successful humoral response against RMC-1.
  • Potential implications for creating future malaria vaccines leveraging this protein.
  • Evaluation methods demonstrated specific antibody production in response to the chimeric protein.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Matos et al. (2026) studied this question.

synapsesocial.com/papers/6a192c0ffab5b468c4415033https://doi.org/10.35259/isi.2026_76333
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model2024 · 2 citations
  2. 2Identification of novel antigenic targets from MSP9 and PM2 proteins for malaria rapid diagnostic tests2026
  3. 3Cellular immunological mechanisms induced by messenger RNA vaccine2026
  4. 4Development and functional evaluation of conventional mRNA vaccine candidates against respiratory syncytial virus2026
  5. 5In silico design of dengue virus epitopes, recombinant antigens and scfv antibodies for serotype-specific diagnostic development2026